Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine

Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine

CONTEXT: Recent studies support the hypothesis that postinfectious irritable bowel syndrome and some irritable bowel syndrome patients display persistent signs of minor mucosal inflammation. Mesalazine has intestinal anti-inflammatory properties including cyclooxygenase and prostaglandin inhibition....

Full description

Bibliographic Details
Main Authors: Mauro Bafutto, José Roberto de Almeida, Nayle Vilela Leite, Enio Chaves Oliveira, Salustiano Gabriel-Neto, Joffre Rezende-Filho
Format: Article
Language:English
Published: Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE) 2011-03-01
Series:Arquivos de Gastroenterologia
Subjects:
Enteropatias inflamatórias
Síndrome do intestino irritável
Mesalamina
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032011000100008&lng=en&tlng=en

Similar Items

Similar Items